THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review

Conclusion: Initial clinical evidence suggests a potential benefit of targeting the angiopoietin/Tie pathway and vascular endothelial growth factor-A over anti–vascular endothelial growth factor-A monotherapy alone, in part due to of the synergistic nature of the pathways.
Source: RETINA - Category: Opthalmology Tags: Review Source Type: research